Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MTOR: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Mechanistic Target of Rapamycin - central kinase regulating autophagy, protein synthesis, and synaptic plasticity in neurodegeneration
| Gene Symbol | MTOR |
| Full Name | Mechanistic Target of Rapamycin |
| Chromosome | 1p36.22 |
| Protein Type | Serine/Threonine Kinase |
| Target Class | Kinase |
| Function | mTOR is a central kinase integrating nutritional, growth factor, and energy signals |
| Mechanism of Action | Prioritized from 1 SciDEX hypotheses, including: APOE-Dependent Autophagy Restoration |
| Druggability | High (0.50) |
| Clinical Stage | Approved |
| Molecular Weight | ~289 kDa |
| Amino Acids | 2549 amino acids |
| Pathways | autophagy-lysosome pathway, lysosomal biogenesis |
| UniProt ID | P42345 |
| NCBI Gene ID | 2475 |
| Ensembl ID | ENSG00000164362 |
| OMIM | 601231 |
| GeneCards | MTOR |
| Human Protein Atlas | MTOR |
| Associated Diseases | AD, ADH, ALS, ALZHEIMER'S DISEASE, AMI, ARM |
| Known Drugs/Compounds | lysosomal cholesterol, LENVATINIB, Zhenwu Decoction, RAPAMYCIN, NMN, QUERCETIN |
| Interactions | ABCG1, SQSTM1, ABCA1, APOE, LOX, PIK3C3 |
| SciDEX Target | View Target Profile |
| SciDEX Hypotheses | APOE-Dependent Autophagy Restoration |
| KG Connections | 5929 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
subgraph Signaling["Signaling"]
MTOR["MTOR"] -->|"regulates"| Mtor["Mtor"]
MTOR["MTOR"] -->|"regulates"| Autophagy["Autophagy"]
MTOR["MTOR"] -.->|"inhibits"| Als["Als"]
MTOR["MTOR"] -.->|"inhibits"| Autophagy_1["Autophagy"]
MTOR["MTOR"] -.->|"inhibits"| Mtor_2["Mtor"]
MTOR["MTOR"] -->|"activates"| Neurodegeneration["Neurodegeneration"]
AKT["AKT"] -->|"activates"| MTOR["MTOR"]
PINK1["PINK1"] -->|"activates"| MTOR["MTOR"]
LC3["LC3"] -->|"activates"| MTOR["MTOR"]
ULK1["ULK1"] -->|"activates"| MTOR["MTOR"]
SQSTM1["SQSTM1"] -->|"activates"| MTOR["MTOR"]
PI3K["PI3K"] -.->|"inhibits"| MTOR["MTOR"]
end
subgraph Interactions["Interactions"]
MTOR["MTOR"] -->|"interacts with"| Als_3["Als"]
end
subgraph Pathology["Pathology"]
MTOR["MTOR"] -->|"associated with"| Als_4["Als"]
MTOR["MTOR"] -->|"associated with"| Mtor_5["Mtor"]
end
style MTOR fill:#4a1a6b,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style Mtor fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autophagy_1 fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Mtor_2 fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Als_3 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Neurodegeneration fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Als_4 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Mtor_5 fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AKT fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style PINK1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style LC3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ULK1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style SQSTM1 fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style PI3K fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| TP53 | associated_with | gene | 1.00 |
| PI3K | activates | gene | 1.00 |
| PI3K | inhibits | gene | 1.00 |
| P62 | activates | gene | 1.00 |
| PI3K | regulates | gene | 1.00 |
| PI3K | associated_with | gene | 1.00 |
| SQSTM1 | activates | gene | 1.00 |
| Mtor | regulates | pathway | 1.00 |
| Autophagy | regulates | pathway | 1.00 |
| Als | inhibits | disease | 1.00 |
| Autophagy | inhibits | pathway | 1.00 |
| Mtor | inhibits | pathway | 1.00 |
| Als | interacts_with | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Mtor | associated_with | pathway | 1.00 |
| Autophagy | associated_with | pathway | 1.00 |
| Cancer | activates | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| Mtor | activates | pathway | 1.00 |
| Glycolysis | activates | pathway | 1.00 |
| Tumor | associated_with | disease | 1.00 |
| Aging | therapeutic_target | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Autophagy | therapeutic_target | pathway | 1.00 |
| Mapk | associated_with | pathway | 1.00 |
| Als | activates | disease | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| Apoptosis | therapeutic_target | pathway | 1.00 |
| Mtor | therapeutic_target | pathway | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| Als | regulates | disease | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| Apoptosis | regulates | pathway | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Aging | activates | disease | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| Tumor | inhibits | disease | 1.00 |
| Cardiovascular | therapeutic_target | disease | 1.00 |
| Alzheimer | therapeutic_target | disease | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| Mitophagy | activates | pathway | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Nf-Κb | activates | pathway | 1.00 |
| Cancer | inhibits | disease | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| AKT | activates | protein | 1.00 |
| PINK1 | activates | gene | 1.00 |
| LC3 | activates | gene | 1.00 |
| ULK1 | activates | gene | 1.00 |
| SQSTM1 | activates | protein | 1.00 |
| PI3K | inhibits | gene | 1.00 |
| PI3K | activates | gene | 1.00 |
| PI3K | associated_with | gene | 1.00 |
| P62 | activates | gene | 1.00 |
| AKT | inhibits | gene | 1.00 |
| AKT | associated_with | gene | 1.00 |
| PI3K | regulates | gene | 1.00 |
| AKT | regulates | gene | 1.00 |
| PI3K | therapeutic_target | gene | 1.00 |
| AKT | therapeutic_target | gene | 1.00 |
| TNF | activates | gene | 1.00 |
| CASP3 | associated_with | gene | 1.00 |
| PTEN | regulates | gene | 1.00 |
| SIRT1 | activates | gene | 1.00 |
| BECN1 | activates | gene | 1.00 |
| GENES | activates | gene | 1.00 |
| AMPK | activates | gene | 1.00 |
| GENES | therapeutic_target | gene | 1.00 |
| AMPK | therapeutic_target | gene | 1.00 |
| GENES | inhibits | gene | 1.00 |
| BCL-2 | activates | gene | 1.00 |
| AMPK | associated_with | gene | 1.00 |
| GENES | regulates | gene | 1.00 |
| MTORC1 | activates | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| CANCER | regulates | gene | 1.00 |
| AUTOPHAGY | associated_with | gene | 1.00 |
| AUTOPHAGY | therapeutic_target | gene | 1.00 |
| MTORC1 | inhibits | gene | 1.00 |
| AGING | activates | gene | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| AUTOPHAGY | regulates | gene | 1.00 |
| MITOCHONDRIA | activates | gene | 1.00 |
| AUTOPHAGY | inhibits | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| HIF | activates | gene | 1.00 |
| APOPTOSIS | associated_with | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| AMYLOID | associated_with | gene | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| INFLAMMATION | regulates | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | activates | gene | 1.00 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| APOE-Dependent Autophagy Restoration | 0.615 | neurodegeneration | Mechanistic role of APOE in neurodegener |
| REDD1-mTOR Axis as the Master Regulator — Preservation Over | 0.586 | neurodegeneration | Why does iron chelation therapy worsen o |
| TREM2-DAP12 Signalosome Enhancement — Boosting PI3K-AKT-mTOR | 0.451 | Alzheimer's disease | TREM2 agonism vs antagonism in DAM micro |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-11 | 0 hypotheses
neurodegeneration | 2026-04-04 | 0 hypotheses
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.557
neurodegeneration | 2026-04-01 | 6 hypotheses Top: 0.615
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Replating Induces mTOR-Dependent Rescue of Protein Synthesis in Charcot-Marie-To [PMID:41876253] | Koenig J, McGuire A, Homedan Y, Alberhas | eNeuro | 2026 | 0 |
| S-equol promotes ferroptosis in triple negative breast cancer by coordinating NC [PMID:41925800] | Ni F, Huang Z, Cui Y, Huang P, Xue Z, Hu | Molecular and cellular biochem | 2026 | 0 |
| Metabolic dysregulation reshapes the immune landscape: The gut microbiota-mTOR a [PMID:41445190] | Li J, Li J, Chen K | Mol Ther | 2026 | 0 |
| Senecavirus a VP2 protein orchestrates PRDX1 degradation through dual autophagy [PMID:41479169] | Li Z, Yang X, Mao J, Zeng P, Qi Y et al. | Autophagy | 2026 | 0 |
| Sishen Wan suppresses colon cancer through dual inhibition of PI3K/AKT/mTOR and [PMID:41490553] | Wang C, Wang R, Xu Q, Jian Q, Li R et al | J Ethnopharmacol | 2026 | 0 |
| Huaiqihuang granule attenuate renal injury in IgA vasculitis nephritis by activa [PMID:41490554] | Ye XL, Zeng LS, Liu Q, Xu WC, Liu H et a | J Ethnopharmacol | 2026 | 0 |
| Inhibition of mTOR Enhances the Efficacy of Proteasome-Dependent Targeted Protei [PMID:41529091] | Liu Y, Sun Y, Song TY, Ni SY, Pu YS et a | Cancer Res | 2026 | 0 |
| Hepatoprotective effects of tetrahydropalmatine against NAFLD through autophagy [PMID:41544727] | Guo X, Yin X, Liu Z, Wang J | J Ethnopharmacol | 2026 | 0 |
| Microglial metabolic reprogramming in Alzheimer's disease: Pathways, mechanisms, [PMID:41651180] | Yang FG, Yang H, Han SW, Wang JT, Gao W | Ageing Res Rev | 2026 | 0 |
| Atractylon induces autophagy-dependent apoptosis in hepatocellular carcinoma cel [PMID:41713198] | Xu J, Yang H, Wei H, Li H, Wang S | Biochem Biophys Res Commun | 2026 | 0 |
| mTOR signaling pathway in primary Sjögren's syndrome: Pathogenesis and potential [PMID:41789635] | Huo R, Yang Y, Wei C, Yang Y, Meng D et | Int J Mol Med | 2026 | 0 |
| Microcystin-LR-induced phosphorylation imbalance and organelle stress: An integr [PMID:41846138] | Teng Z, Shahzad A, Xu Z, Xia J, Zhang J | J Hazard Mater | 2026 | 0 |
| Copper deficiency impairs oligodendrocyte maturation and social behavior via mit [PMID:41920999] | Usui N, Doi M, Berto S, Matsuoka K, Ishi | Sci Adv | 2026 | 0 |
| Crosstalk between inflammation and autophagy in CeD organoids. [PMID:41933042] | Bellomo C, Furone F, Auricchio R, D'Anie | Sci Rep | 2026 | 0 |
| Designed Liquid Crystalline Nanoassemblies From Clinically Validated Polyunsatur [PMID:41937329] | Akanchise T, Luo F, Angelov B, Deng Y, A | Adv Healthc Mater | 2026 | 0 |
| Concept and connotation of the geroprotective and anti-aging effects of metformi [PMID:41942023] | Aedh AI, Al-Kuraishy HM, Shokr MM, Alruw | Mol Cell Endocrinol | 2026 | 0 |
| miR-155 and the orchestration of cell-death evasion and chemoresistance in cance [PMID:41946306] | Abdul-Rahman SY, Shareef A, Jyothi SR, N | Cancer Treat Res Commun | 2026 | 0 |
| The role of mTOR signaling in regulating the quality of mammalian oocytes. [PMID:41949718] | Bai X, Zhu P, Wu X | J Assist Reprod Genet | 2026 | 0 |
| Deciphering the role of SIRT6 in suppressing the AMPK-mTOR-TFEB axis: regulation [PMID:41957523] | Li CS, Jin H, Meng R, Baek SW, Kim SH et | Cancer Gene Ther | 2026 | 0 |
| Why dietary interventions fail or succeed in ageing: metabolic resilience as the [PMID:41962762] | Murillo-Cancho AF, Lozano-Paniagua D, Ma | Clin Nutr ESPEN | 2026 | 0 |